NationThailand-Nov 25

AstraZeneca’s Covid-19 vaccine should be available in Thailand in the first half of 2021, under a technology-transfer deal signed with the Thai government.

Siam Bioscience will receive the technology for the vaccine, which was developed by a team at Oxford University. The Thai firm expects to register the vaccine with the Food and Drug Administration in the next six months, and produce enough doses for Thailand and ASEAN neighbors in the first half of 2021. Initially, 26 million doses will be produced for 13 million Thais. Siam Bioscience has a production capacity of 180 million to 200 million doses per year or 15 million doses per month.

Disease Control Department director-general Opas Karnkawinpong estimates Thailand needs 2 million doses per month. The rest will be exported to neighboring countries.

Read more at: https://www.nationthailand.com/news/30398519?utm_source=homepage_hilight&utm_medium=internal_referral